Hospital
Phc-Fort Morgan INC
Phc-Fort Morgan INC was paid $1.30M by Medicaid between Jan 2018 and Apr 2022, across 50 billing codes. Its largest line is 99283, emergency room visit (moderate) — 44% of everything it billed.
33Billing provider infoPHC-FORT MORGAN INC
FORT MORGAN, CO 80701
FORT MORGAN, CO 80701
33aNPI1477638971assigned 10/25/2006
33bProvider typeRural Acute Care Hospital
28Total paid$1.30M
24GClaims23,857
24DCodes billed50
24AFirst – last monthJan 2018 – Apr 2022
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DILLON, TERRANCE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,364 | $330K | |
| 2019 | 5,783 | $323K | |
| 2020 | 3,403 | $176K | |
| 2021 | 5,912 | $324K | |
| 2022 | 2,395 | $149K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 44% | 4,660 | 4,457 | $579K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 4,540 | 4,311 | $423K |
| 80053 | Comprehensive metabolic panel | 5.1% | 2,517 | 2,327 | $66K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.5% | 496 | 471 | $59K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.9% | 161 | 147 | $37K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.9% | 682 | 642 | $25K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 313 | 288 | $21K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,936 | 2,596 | $12K |
| 0011A | <1% | 109 | 97 | $9K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 122 | 110 | $8K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 71 | 26 | $8K |
| 0012A | <1% | 90 | 83 | $7K |
38 more codes
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 486 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,331 | $7K |
| 86701 | <1% | 108 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 68 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 126 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 77 | $4K |
| 87070 | <1% | 80 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 58 | $3K |
| 59025 | Fetal non-stress test | <1% | 16 | $3K |
| 86803 | <1% | 124 | $2K | |
| 80055 | <1% | 55 | $2K | |
| 87653 | <1% | 18 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 66 | $858.60 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 396 | $597.33 |
| 80306 | <1% | 25 | $579.30 | |
| 87081 | <1% | 34 | $569.36 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 13 | $297.55 |
| 80061 | Lipid panel | <1% | 13 | $252.36 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 33 | $175.47 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 46 | $170.16 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 430 | $153.72 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 43 | $133.69 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 58 | $109.96 |
| 82950 | <1% | 12 | $48.20 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 312 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 12 | $0.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 123 | $0.00 |
| 81003 | 0% | 28 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 13 | $0.00 |
| 81001 | 0% | 592 | $0.00 | |
| 71045 | Radiologic examination, chest; single view | 0% | 86 | $0.00 |
| 87430 | 0% | 49 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 51 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 40 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 14 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 59 | $0.00 |
| 83690 | 0% | 46 | $0.00 | |
| G0378 | Hospital observation service, per hour | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDILLON, TERRANCE (ASSISTANT SECRETARY)
| Provider | Location | Paid |
|---|---|---|
| RCHP Billings - Missoula LLC | Missoula, MT | $13.10M |
| Lake Cumberland Surgery Center LP | Somerset, KY | $8.72M |
| Crockett Hospital LLC | Lawrenceburg, TN | $4.56M |
| Lohman Endoscopy Center, LLC | Las Cruces, NM | $4.45M |
| Dodge City Healthcare Group LLC | Dodge City, KS | $737K |
| Kershaw Hospital LLC | Elgin, SC | $695K |
| Kentucky Hospital, LLC | Stanton, KY | $431K |
| Pinelake Physician Practice LLC | Hickman, KY | $263K |
| Rehabcare Group East, LLC | Greenfield, WI | $208K |
| ST. Mary's Specialty LLC | Russellville, AR | $136K |
| Rehabcare Group East LLC | Kirkwood, MO | $29K |
| Rehabcare Group East, LLC | Asheville, NC | $23K |
| DLP Marquette General Hospital LLC | Marquette, MI | $23K |
| SJRMC Interventional Radiology Services LLC | Lewiston, ID | $19K |
| DLP Marquette General Hospital LLC | Marquette, MI | $16K |
| The Therapy Group, LLC | Houma, LA | $10K |
| Havasu Regional Medical Center LLC | Lake Havasu City, AZ | $6K |
| Peoplefirst Virginia, LLC | Timonium, MD | $3K |
| Amg-Southern Tennessee LLC | Estill Springs, TN | $1K |
| Rehabcare Group East, LLC | Shalimar, FL | $471.77 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.